Increased mRNA levels of ERG16, CDR, and MDR1 correlate, with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 7, 1997, Pages 1482-1487

  White, Theodore C ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; MESSENGER RNA; PYRROLE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CROSS RESISTANCE; FUNGAL GENETICS; FUNGUS CULTURE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; STEROL SYNTHESIS;

EID: 0030757227     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.7.1482     Document Type: Article

References (48)

1. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1995. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
2. Ben-Yaacov, R., S. Knoller, G. A. Caldwell, J. M. Becker, and Y. Koltin. 1994. Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob. Agents Chemother. 38:648-652.
3. Cannon, R. Personal communication.
4. Chen, C., T. G. Turi, D. Sanglard, and J. C. Loper. 1987. Isolation of the Candida tropicalis gene for P450 lanosterol demethylasc and its expression in Saccharomyces cerevisiae. Biochem. Biophys. Res. Commun. 146:1311-1317.
5. Clark, F. S., T. Parkinson, C. A. Hitchcock, and N. A. R. Gow. 1996. Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance. Antimicrob. Agents Chemother. 40:419-425.
6. Doignon, F., M. Aigle, and G. P. Ribereau. 1993. Resistance to imidazoles and triazoles in Saccharomyces cerevisiae as a new dominant marker. Plasmid 30:224-233.
7. Fling, M. E., J. Kopf, A. Tamarkin, J. A. Gorman, H. A. Smith, and Y. Koltin. 1991. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol. Gen. Genet. 227:318-329.
8. Galgiani, J., M. Bartlett, M. Espinel-Ingroff, R. Fromtling, M. Pfaller, and M. Rinaldi. 1992. Reference method for broth dilution antifungal susceptibility testing of yeasts: proposed standard, vol. 12. National Committee for Clinical Laboratory Standards, Villanova, Pa.
9. Goldway, M., D. Teff, R. Schmidt, A. B. Oppenheim, and Y. Koltin. 1995. Multidrug resistance in Candida albicans: disruption of the BENr gene. Antimicrob. Agents Chemother. 39:422-426.
10. Greenspan, D., J. Greenspan, M. Schiodt, and J. Pindborg. 1990. AIDS and the mouth, p. 91-102. Munksgaard, Copenhagen, Denmark.
11. Hitchcock, C. A. 1993. Resistance of Candida albicans to azole antifungal agents. Biochem. Soc. Trans. 21:1039-1047.
12. Kalb, V. F., J. C. Loper, C. R. Dey, C. W. Woods, and T. R. Sutter. 1986. Isolation of a cytochrome P-450 structural gene from Saccharomyces cerevisiae. Gene 45:237-245.
13. Kelly, R., S. M. Miller, M. H. Lai, and D. R. Kirsch. 1990. Cloning and characterization of the 2,3-oxidosqualene cyclase-coding gene of Candida albicans. Gene 87:177-183.
14. Kenna, S., H. F. Bligh, P. F. Watson, and S. L. Kelly. 1989. Genetic and physiological analysis of azole sensitivity in Saccharomyces cerevisiae. J. Med. Vet. Mycol. 27:397-406.
15. Kirsch, D. R., M. H. Lai, and J. O'Sullivan. 1988. Isolation of the gene for cytochrome P450L1A1 (lanosterol 14 alpha-demethylase) from Candida albicans. Gene 68:229-237.
16. Kohler, G., and N. Agabian. Personal communication.
17. Kurtz, M. Personal communication.
18. Kwon-Chung, K. J., and J. E. Bennett. 1992. Medical mycology, p. 81-104. Lea & Febiger, Philadelphia, Pa.
19. Lai, M. H., and D. R. Kirsch. 1989. Nucleotide sequence of cytochrome P450 L1A1 (lanosterol 14 alpha-demethylase) from Candida albicans. Nucleic Acids Res. 17:804.
20. Law, D., C. B. Moore, H. M. Wardle, L. A. Ganguli, M. G. Keaney, and D. W. Denning. 1994. High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J. Antimicrob. Chemother. 34:659-668.
21. Losberger, C., and J. F. Ernst. 1989. Sequence of the Candida albicans gene encoding actin. Nucleic Acids Res. 17:9488.
22. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
23. Marger, M. D., and M. H. Saier, Jr. 1993. A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport. Trends Biochem. Sci. 18:13-20.
24. Michaelis, S., and C. Berkower. 1995. Sequence comparison of yeast ATP binding cassette (ABC) proteins. Cold Spring Harbor Symp. Quant. Biol. 60:291-309.
25. Odds, F. C. 1988. Candida and candidosis: a review and bibliography. Bailliere Tindall, London, United Kingdom.
26. Odds, F. C. 1996. Resistance of clinically important yeasts to antifungal agents. Int. J. Antimicrob. Agents 6:145-147.
27. Parkinson, T., D. J. Falconer, and C. A. Hitchcock. 1995. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob. Agents Chemother. 39:1696-1699.
28. Penefsky, H. S. 1979. A centrituged-column procedure for the measurement of ligand binding by beef heart F1. Methods Enzymol. 56:527-530.
29. Pfaller, M. A., C. J. Rhine, S. W. Redding, J. Smith, G. Farinacci, A. W. Fothergill, and M. G. Rinaldi. 1994. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J. Clin. Microbiol. 32:59-64.
30. Prasad, R., W. P. De, A. Goffeau, and E. Balzi. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:320-329.
31. Raymond, M., D. Dignard, N. Mainville, and D. Y. Thomas. Personal communication.
32. Redding, S., J. Smith, G. Farinacci, M. Rinaldi, A. Fothergill, C. J. Rhine, and M. Pfaller. 1994. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin. Infect. Dis. 18:240-242.
33. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinellngroff, M. A. Ghannoum, M. Lancaster, F. C. Odds, M. G. Rinaldi, T. J. Walsh, and A. L. Barry. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin. Infect. Dis. 24:235-247.
34. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
35. Rodríguez-Tudela, J. L., J. V. Martínez-Suárez, F. Dronda, F. Laguna, F. Chaves, and E. Valencia. 1995. Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients. J. Antimicrob. Chemother. 35:793-804.
36. Roessner, C. A., C. Min, S. H. Hardin, H. L. Harris, J. C. McCollum, and A. I. Scott. 1993. Sequence of the Candida albicans erg7 gene. Gene 127: 149-150.
37. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
38. Sanglard, D. Personal communication.
39. Sanglard, D., F. Ischer, M. Monod, and J. Bille. 1997. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143: 405-416.
40. Sanglard, D., F. Ischer, M. Monod, and J. Bille. 1996. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob. Agents Chemother. 40:2300-2305.
41. Sanglard, D., K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
42. Scherer, S., and Y. Ran. 1996. Candida albicans information: webpage http: //alces.med.umn.edu/Candida.html.
43. Sturtevant, J., and R. Calderone. Personal communication.
44. White, T. C. 1997. The presence of an amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14α demethylase in Candida albicans. Antimicrob. Agents Chemother. 41:1488-1494.
45. White, T. C. Unpublished data.
46. White, T. C., and N. Agabian. 1995. Candida albicans-secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors. J. Bacteriol. 177:5215-5221.
47. White, T. C., G. A. Kohler, S. H. Miyasaki, and N. Agabian. 1995. Expression of virulence factors in Candida albicans. Can. J. Bot. 73(Suppl. 1):S1058-S1064.
48. White, T. C., M. A. Pfaller, R. G. Rinaldi, J. Smith, and S. W. Redding. 1997. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient. Oral Dis. 3(Suppl. 1):S102-S109.